A detailed history of Nuveen Asset Management, LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 790,552 shares of CDMO stock, worth $9.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
790,552
Previous 244,212 223.72%
Holding current value
$9.71 Million
Previous $1.74 Million 416.12%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.7 - $12.45 $3.66 Million - $6.8 Million
546,340 Added 223.72%
790,552 $9 Million
Q2 2024

Aug 09, 2024

BUY
$6.34 - $9.28 $104,958 - $153,630
16,555 Added 7.27%
244,212 $1.74 Million
Q1 2024

May 13, 2024

BUY
$5.86 - $8.79 $358,977 - $538,466
61,259 Added 36.81%
227,657 $1.53 Million
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $7,103 - $14,636
1,531 Added 0.93%
166,398 $1.08 Million
Q3 2023

Nov 14, 2023

SELL
$9.4 - $14.04 $20,257 - $30,256
-2,155 Reduced 1.29%
164,867 $1.56 Million
Q2 2023

Aug 14, 2023

BUY
$12.96 - $20.93 $57,412 - $92,719
4,430 Added 2.72%
167,022 $2.33 Million
Q1 2023

May 15, 2023

SELL
$13.48 - $18.79 $103,836 - $144,739
-7,703 Reduced 4.52%
162,592 $3.05 Million
Q4 2022

Feb 14, 2023

SELL
$12.61 - $18.74 $74,272 - $110,378
-5,890 Reduced 3.34%
170,295 $2.35 Million
Q3 2022

Nov 14, 2022

SELL
$15.33 - $20.36 $3.32 Million - $4.41 Million
-216,411 Reduced 55.12%
176,185 $3.37 Million
Q2 2022

Aug 15, 2022

SELL
$11.63 - $21.55 $624,321 - $1.16 Million
-53,682 Reduced 12.03%
392,596 $5.99 Million
Q1 2022

May 16, 2022

SELL
$16.63 - $27.73 $3.76 Million - $6.27 Million
-226,171 Reduced 33.63%
446,278 $9.66 Million
Q4 2021

Feb 14, 2022

SELL
$20.7 - $34.18 $3.65 Million - $6.03 Million
-176,552 Reduced 20.8%
672,449 $16.5 Million
Q3 2021

Nov 12, 2021

SELL
$19.05 - $28.32 $1.78 Million - $2.64 Million
-93,208 Reduced 9.89%
849,001 $17.8 Million
Q2 2021

Aug 16, 2021

SELL
$18.93 - $25.65 $1.46 Million - $1.98 Million
-77,180 Reduced 7.57%
942,209 $24.2 Million
Q1 2021

May 17, 2021

BUY
$11.86 - $21.77 $5.85 Million - $10.7 Million
493,121 Added 93.7%
1,019,389 $18.6 Million
Q4 2020

Feb 16, 2021

BUY
$7.25 - $11.76 $962,314 - $1.56 Million
132,733 Added 33.73%
526,268 $6.07 Million
Q3 2020

Nov 16, 2020

BUY
$6.53 - $8.6 $75,793 - $99,820
11,607 Added 3.04%
393,535 $3 Million
Q2 2020

Aug 14, 2020

SELL
$4.11 - $6.78 $15,634 - $25,791
-3,804 Reduced 0.99%
381,928 $2.51 Million
Q1 2020

May 14, 2020

BUY
$3.15 - $7.39 $323,854 - $759,773
102,811 Added 36.34%
385,732 $1.97 Million
Q4 2019

Feb 14, 2020

BUY
$5.01 - $8.16 $204,673 - $333,360
40,853 Added 16.88%
282,921 $2.17 Million
Q3 2019

Nov 14, 2019

BUY
$5.07 - $7.08 $225,554 - $314,975
44,488 Added 22.52%
242,068 $1.28 Million
Q2 2019

Aug 15, 2019

BUY
$3.43 - $5.6 $677,699 - $1.11 Million
197,580 New
197,580 $1.11 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $763M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.